technetium tc 99m mertiatide has been researched along with Escherichia coli Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biyabani, SR; Jalbani, IK | 1 |
Dou, S; Gupta, S; Hnatowich, DJ; Liu, G; Rusckowski, M | 1 |
2 other study(ies) available for technetium tc 99m mertiatide and Escherichia coli Infections
Article | Year |
---|---|
Late presentation of posterior urethral valves.
Topics: Adult; Anti-Bacterial Agents; Cystoscopy; Electrocoagulation; Escherichia coli; Escherichia coli Infections; Hematuria; Humans; Infant, Newborn; Male; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Mertiatide; Treatment Outcome; Urethra; Urethral Obstruction; Urinary Tract Infections; Urination Disorders; Urography | 2014 |
Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent.
Topics: Animals; Bacteriophage M13; Escherichia coli Infections; Isotope Labeling; Metabolic Clearance Rate; Mice; Myositis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Mertiatide; Tissue Distribution | 2004 |